Virtual Reality to Treat Anxiety in Parkinson’s Disease

Not Applicable

Recruiting

• Conditions: Parkinson's disease; Anxiety; Neurological - Parkinson's disease; Mental Health - Anxiety

• Registration Number: ACTRN12618001508268
• Lead Sponsor: niversity of Queensland Centre for Clinical Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-09-07
• Last Update Posted: 16 March 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Established PD diagnosis according to the United Kingdom Brain Bank criteria and having a diagnosis of anxiety according to the DSM-5 criteria or the Parkinson’s Anxiety Scale
(PAS). Patients must score greater than >13 for PAS Total or >10 for PAS Persistent or >5 for PAS Episodic or >4 for PAS avoidance subscales.

Exclusion Criteria

Comorbid neurological disorders, currently receiving deep brain stimulation (DBS) therapy, a high risk of suicide identified by a neurologist or by the Mini International Neuropsychiatric Interview (MINI-Plus) suicide item, or moderate to severe cognitive impairment identified by the neurologist or scoring <22 in the Montreal Cognitive Assessment (MoCA) or PD patients currently receiving psychotherapy. Exclusion criteria will apply at baseline, post and follow-up assessments.

Study & Design

• Study Type: Interventional
• Study Design: Not specified